[HTML][HTML] Current epidemiology of Pneumocystis pneumonia
A Morris, JD Lundgren, H Masur… - Emerging infectious …, 2004 - ncbi.nlm.nih.gov
Pneumocystis pneumonia (PCP) has historically been one of the leading causes of disease
among persons with AIDS. The introduction of highly active antiretroviral therapy in …
among persons with AIDS. The introduction of highly active antiretroviral therapy in …
Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy
… Combination antiretroviral therapy and the risk of myocardial infarction [published
correction appears in N Engl J Med. 2004;350:955]. N Engl J Med. 2003; 349: 1993–2003.Crossref…
correction appears in N Engl J Med. 2004;350:955]. N Engl J Med. 2003; 349: 1993–2003.Crossref…
Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients
…, N Clumeck, S Collins, W Gerlich, J Lundgren… - Journal of …, 2005 - Elsevier
2. Background Globally, an estimated 370–400 million people are chronic carriers of
hepatitis B virus (HBV) and over 180 million people are chronic carriers of hepatitis C virus (HCV). …
hepatitis B virus (HBV) and over 180 million people are chronic carriers of hepatitis C virus (HCV). …
[HTML][HTML] Remdesivir for the treatment of Covid-19
…, RL Atmar, CB Creech, J Lundgren… - … England Journal of …, 2020 - Mass Medical Soc
Background Although several therapeutic agents have been evaluated for the treatment of
coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be …
coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be …
Remdesivir for the treatment of Covid-19—preliminary report
…, RL Atmar, CB Creech, J Lundgren… - … England Journal of …, 2020 - discovery.ucl.ac.uk
BACKGROUND: Although several therapeutic agents have been evaluated for the treatment
of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be …
of coronavirus disease 2019 (Covid-19), no antiviral agents have yet been shown to be …
Initiation of antiretroviral therapy in early asymptomatic HIV infection.
JD Lundgren, AG Babiker, F Gordin… - The New England …, 2015 - europepmc.org
Background Data from randomized trials are lacking on the benefits and risks of initiating
antiretroviral therapy in patients with asymptomatic human immunodeficiency virus (HIV) …
antiretroviral therapy in patients with asymptomatic human immunodeficiency virus (HIV) …
Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy
…, A Antela, S Allan, AN Phillips, J Lundgren… - Jama, 2016 - jamanetwork.com
Importance A key factor in assessing the effectiveness and cost-effectiveness of antiretroviral
therapy (ART) as a prevention strategy is the absolute risk of HIV transmission through …
therapy (ART) as a prevention strategy is the absolute risk of HIV transmission through …
[HTML][HTML] Inflammatory and coagulation biomarkers and mortality in patients with HIV infection
…, B Ledergerber, J Lundgren, J Neuhaus… - PLoS …, 2008 - journals.plos.org
… Jens Lundgren reported honoraria and research grants from Boehringer-Ingelheim, Roche,
Abbott, Bristol-Myers Squibb, Merck Sharp & Dohme, GlaxoSmithKline, Tibotec, Pfizer, and …
Abbott, Bristol-Myers Squibb, Merck Sharp & Dohme, GlaxoSmithKline, Tibotec, Pfizer, and …
Changing patterns of mortality across Europe in patients infected with HIV-1
…, I Yust, JN Bruun, AN Phillips, JD Lundgren - The Lancet, 1998 - thelancet.com
… A Phillips supervised statistical analyses and contributed to the writing of the paper, J
Lundgren, as overall study co-ordinator supervised the project and contributed to the statistical …
Lundgren, as overall study co-ordinator supervised the project and contributed to the statistical …
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
…, ADA Monforte, F De Wolf, P Reiss, JD Lundgren… - The Lancet, 2002 - thelancet.com
Background Insufficient data are available from single cohort studies to allow estimation of
the prognosis of HIV-1 infected, treatment-naive patients who start highly active antiretroviral …
the prognosis of HIV-1 infected, treatment-naive patients who start highly active antiretroviral …